Zobrazeno 1 - 10
of 284
pro vyhledávání: ''
Publikováno v:
Journal of Child Neurology. 36:281-287
Background: Rufinamide, a triazole derivative, is a new-generation antiseizure medication with a novel mechanism of action. We evaluated the efficacy and safety of rufinamide treatment in children with epilepsy younger than 4 years at our center. Met
Autor:
Kathie L Rogers, Veena Ramachandran, Randall J. Cohrs, Charles Grose, Wallen Jackson, Stephen C Elliott, Daniel J. Bonthius, Miles Weinberger, John E. Carpenter
Publikováno v:
Journal of Child Neurology
Varicella-zoster virus vaccination is recommended for virtually all young children in the United States, Canada, and several other countries. Varicella vaccine is a live attenuated virus that retains some of its neurotropic properties. Herpes zoster
Autor:
Raymundo Marcelo, Brin Freund
Publikováno v:
Journal of Child Neurology. 35:844-851
Aims: To conduct a review of the literature on the use of botulinum toxin for the treatment of pediatric chronic migraine. Methods: A review of the literature was performed using EMBASE, PubMed, and Cochrane/Ovid. Using our inclusion and exclusion cr
Publikováno v:
J Child Neurol
Lacosamide, an antiepileptic drug prescribed for children with refractory focal epilepsy, is generally well tolerated, with dose-dependent adverse effects. We describe 4 children who developed a movement disorder in conjunction with the initiation an
Autor:
Laura Lucaccioni, L Ori, Maria Carolina Bariola, Alberto Berardi, Licia Lugli, Fabrizio Ferrari
Publikováno v:
Journal of Child Neurology. 34:937-943
In recent years, the clinical spectrum of pyridoxine phosphate oxidase (PNPO) deficiency has broadened. There are a growing number of patients with a transient or lasting response to pyridoxine in addition to cases that respond more traditionally to
Publikováno v:
Journal of Child Neurology. 34:806-814
Idiopathic intracranial hypertension, or pseudotumor cerebri, is an increase in cerebrospinal fluid pressure of unknown etiology. It is mostly seen in adults, less frequently in adolescents, rarely in younger children. Only 5 infants meeting idiopath
Publikováno v:
J Child Neurol
Neuronal intranuclear inclusion disease is a rare, neurodegenerative disorder with onset in childhood. We report a single case natural history over 10 years and present a review of juvenile parkinsonism and neuronal intranuclear inclusion disease. Ou
Publikováno v:
Journal of Child Neurology. 34:739-747
Traumatic brain injury causes significant morbidity in youth, and headache is the most common postconcussive symptom. No established guidelines exist for pediatric post-traumatic headache management. We aimed to characterize common clinical practices
Autor:
Peter W. Glynn, Satyanarayana Gedela, Anup D. Patel, Sravya Gedela, Daniel A. Freedman, Ann Salvator
Publikováno v:
Journal of Child Neurology. 34:735-738
Clobazam is a commonly used long-acting benzodiazepine approved by the US Food and Drug Administration (FDA) to treat seizures associated with Lennox Gastaut syndrome. The FDA approved maximum dosage of clobazam is 1 mg/kg/d or a total of 40 mg a day
Autor:
Kamil Detyniecki, Lawrence J. Hirsch, Richard Buchsbaum Bs, Jennifer Bonito Bs, Kenneth Kato Bs, Qianyu Wang Ba, Hyunmi Choi, Rafal D. Mazur
Publikováno v:
Journal of Child Neurology. 34:593-597
The main objective of this study was to assess the efficacy, safety, and retention rates of levetiracetam monotherapy in children with epilepsy. A retrospective review of pediatric patients receiving levetiracetam monotherapy at 2 large tertiary epil